FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy
FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy Ophthalmology Times Europe
Finance, IT & News
FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy Ophthalmology Times Europe
Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo Contemporary OB/GYN
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer The American Journal of Managed Care
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients Pharmacy Times
Boeing’s smallest 737 Max wins approval after years of delay tied to crashes The Washington Post